Validation of an LC-MS/MS method to determine five immunosuppressants with deuterated internal standards including MPA

BMC Clinical Pharmacology

Volumn 12, Issue , 2012, Pages

  Buchwald, Armin ^a   Winkler, Karl ^a   Epting, Thomas ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; EVEROLIMUS; ISOTOPE; MYCOPHENOLIC ACID; PLASMA PROTEIN; RAPAMYCIN; TACROLIMUS; ZINC SULFATE; CYCLOSPORIN; DEUTERIUM; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; DRUG DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIMIT OF QUANTITATION; SOLID PHASE EXTRACTION; STANDARD; TANDEM MASS SPECTROMETRY; BLOOD; DRUG MONITORING; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METHODOLOGY; REPRODUCIBILITY; VALIDATION STUDY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, LIQUID; CYCLOSPORINE; DEUTERIUM; DRUG MONITORING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MASS SPECTROMETRY; MYCOPHENOLIC ACID; REPRODUCIBILITY OF RESULTS; SIROLIMUS; TACROLIMUS;

EID: 84855601062     PISSN: None     EISSN: 14726904     Source Type: Journal    
DOI: 10.1186/1472-6904-12-2     Document Type: Article

References (24)

1. Beckebaum S, Armstrong VW, Cicinnati VR, Streit F, Klein CG, Gerken G, Paul A, Oellerich M. Pharmacokinetics of mycophenolic acid and its glucuronide metabolites in stable adult liver transplant recipients with renal dysfunction on a low-dose calcineurin inhibitor regimen and mycophenolate mofetil. Ther Drug Monit 2009, 31(2):205-210. 10.1097/FTD.0b013e31819743d9, 19307937.
2. Ekberg H, Tedesco-Silva H, Demirbas A, Vitko S, Nashan B, Gurkan A, Margreiter R, Hugo C, Grinyo JM, Frei U, et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 2007, 357(25):2562-2575. 10.1056/NEJMoa067411, 18094377.
3. Srinivas TR, Meier-Kriesche HU. Minimizing immunosuppression, an alternative approach to reducing side effects: objectives and interim result. Clin J Am Soc Nephrol 2008, 3(Suppl 2):S101-116. 3152278, 18308998.
4. Ghoshal AK, Soldin SJ. IMx tacrolimus II assay: is it reliable at low blood concentrations? A comparison with tandem MS/MS. Clin Biochem 2002, 35(5):389-392. 10.1016/S0009-9120(02)00338-7, 12270769.
5. Schneider HSW. Tandem-Massenspektrometrie in der therapeutischen Arzneimittelspiegel-Bestimmung: Praxis und Tücken der Anwendung. J Lab Med 2006, 6(30):428-437.
6. Seger CVM. Immunosuppressant drug monitoring - a routine undertaking?. J Lab Med 2010, 3(34):117-128.
7. Taylor PJ. Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry. Clin Biochem 2005, 38(4):328-334. 10.1016/j.clinbiochem.2004.11.007, 15766734.
8. Meinitzer A, Gartner G, Pilz S, Stettin M. Ultra fast liquid chromatography-tandem mass spectrometry routine method for simultaneous determination of cyclosporin A, tacrolimus, sirolimus, and everolimus in whole blood using deuterated internal standards for cyclosporin A and everolimus. Ther Drug Monit 2010, 32(1):61-66. 10.1097/FTD.0b013e3181c49a00, 20010460.
9. O'Halloran S, Ilett KF. Evaluation of a deuterium-labeled internal standard for the measurement of sirolimus by high-throughput HPLC electrospray ionization tandem mass spectrometry. Clin Chem 2008, 54(8):1386-1389. 10.1373/clinchem.2008.103952, 18664442.
10. Taylor PJ, Brown SR, Cooper DP, Salm P, Morris MR, Pillans PI, Lynch SV. Evaluation of 3 internal standards for the measurement of cyclosporin by HPLC-mass spectrometry. Clin Chem 2005, 51(10):1890-1893. 10.1373/clinchem.2005.055160, 16189380.
11. Annesley TM, Clayton LT. Quantification of mycophenolic acid and glucuronide metabolite in human serum by HPLC-tandem mass spectrometry. Clin Chem 2005, 51(5):872-877. 10.1373/clinchem.2004.047357, 15746301.
12. Ceglarek U, Casetta B, Lembcke J, Baumann S, Fiedler GM, Thiery J. Inclusion of MPA and in a rapid multi-drug LC-tandem mass spectrometric method for simultaneous determination of immunosuppressants. Clin Chim Acta 2006, 373(1-2):168-171. 10.1016/j.cca.2006.05.019, 16806142.
13. Bogusz MJ, Enazi EA, Hassan H, Abdel-Jawaad J, Ruwaily JA, Tufail MA. Simultaneous LC-MS-MS determination of cyclosporine A, tacrolimus, and sirolimus in whole blood as well as mycophenolic acid in plasma using common pretreatment procedure. J Chromatogr B Analyt Technol Biomed Life Sci 2007, 850(1-2):471-480. 10.1016/j.jchromb.2006.12.048, 17239667.
14. Ceglarek U, Lembcke J, Fiedler GM, Werner M, Witzigmann H, Hauss JP, Thiery J. Rapid simultaneous quantification of immunosuppressants in transplant patients by turbulent flow chromatography combined with tandem mass spectrometry. Clin Chim Acta 2004, 346(2):181-190. 10.1016/j.cccn.2004.03.017, 15256319.
15. Seger C, Tentschert K, Stoggl W, Griesmacher A, Ramsay SL. A rapid HPLC-MS/MS method for the simultaneous quantification of cyclosporine A, tacrolimus, sirolimus and everolimus in human blood samples. Nat Protoc 2009, 4(4):526-534. 10.1038/nprot.2009.25, 19325549.
16. Koster RA, Dijkers EC, Uges DR. Robust, high-throughput LC-MS/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood. Ther Drug Monit 2009, 31(1):116-125. 10.1097/FTD.0b013e318192304c, 19065123.
17. Annesley TM, Clayton L. Simple extraction protocol for analysis of immunosuppressant drugs in whole blood. Clin Chem 2004, 50(10):1845-1848. 10.1373/clinchem.2004.037416, 15308598.
18. US Department of Health and Human Services FaDA, Reserach CfDEa Bioanalytical method validation. 2001, US Department of Health and Human Services FaDA, Reserach CfDEa.
19. Wayne P. Evaluation of precision performance of clinical chemistry devices. National Committee for Clinical Laboratory Standards 1992,
20. Vogeser M, Seger C. Pitfalls associated with the use of liquid chromatography-tandem mass spectrometry in the clinical laboratory. Clin Chem 2010, 56(8):1234-1244. 10.1373/clinchem.2009.138602, 20511452.
21. Chambers E, Wagrowski-Diehl DM, Lu Z, Mazzeo JR. Systematic and comprehensive strategy for reducing matrix effects in LC/MS/MS analyses. J Chromatogr B Analyt Technol Biomed Life Sci 2007, 852(1-2):22-34. 10.1016/j.jchromb.2006.12.030, 17236825.
22. Vogeser M. Instrument-specific matrix effects of calibration materials in the LC-MS/MS analysis of tacrolimus. Clin Chem 2008, 54(8):1406-1408. 10.1373/clinchem.2008.105643, 18664452.
23. Annesley TM. Methanol-associated matrix effects in electrospray ionization tandem mass spectrometry. Clin Chem 2007, 53(10):1827-1834. 10.1373/clinchem.2007.090811, 17702856.
24. Wallemacq P, Armstrong VW, Brunet M, Haufroid V, Holt DW, Johnston A, Kuypers D, Le Meur Y, Marquet P, Oellerich M, et al. Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference. Ther Drug Monit 2009, 31(2):139-152. 10.1097/FTD.0b013e318198d092, 19177031.